Edgewise Therapeutics, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
10,428,437
Value ($000)
328,496
Weight
3.5%
2021 Q1 - 2026 Q1 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).